Karo Pharma
Mark Keatley, born in 1957, holds a MA and MPhil from Cambridge University and an MBA from Stanford Graduate School of Business. Mark Keatley has been CFO of STADA AG and Actavis Group, two leading European manufacturers of generic and OTC medicines. He is a Board member of Recipharm AB and Neuraxpharm AG. Previously he has served as a board member of MS Pharma and Medichem, S.A., as a Senior Partner at Albrecht Prock & Partners AB, as CFO of companies in contract manufacturing, biotechnology, and natural resources, and as a Division Manager at the International Finance Corporation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Karo Pharma
2 followers
Karo Pharma delivers smart choices for everyday healthcare. Karo Pharma own sand commercializes branded, original over-the-counter products and prescription medicines across a range of everyday categories, including intimate care; dermatology; footcare; pain, cough and cold; wellness; and Rx pharma care.